MedTrace Logo

Acetaminophen Randomized Controlled Trial

NCT02737124 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2018-07-26

No results posted yet for this study

Summary

Patients that are to undergo isolated meniscectomy will be randomized to 2 cohorts: one will take the FDA recommended dose of acetominophen (1000mg) 24hrs before surgery, one will be given a similarly looking placebo pill. A multitude of post-op variables will be included, mainly pain scores and morphine equivalent doses at different time points.

Conditions

  • Post Operative Pain

Interventions

DRUG

Acetaminophen

Acetaminophen will be given 24 hours before scheduled surgery.

OTHER

Placebo

Placebo will be given to subjects 24 hours before scheduled surgery.

Sponsors & Collaborators

Principal Investigators

  • Eric Strauss, MD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-16
Primary Completion
2018-03-01
Completion
2018-03-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02737124 on ClinicalTrials.gov